The ROE as of November 2024 (TTM) for TRACON Pharmaceuticals, Inc. (TCON) is -237.65%

According to TRACON Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -237.65%. This represents a change of 622.57% compared to the average of -32.89% of the last 4 quarters.

TRACON Pharmaceuticals, Inc. (TCON) Historical ROE (quarterly & annually)

How has TCON ROE performed in the past?

The mean historical ROE of TRACON Pharmaceuticals, Inc. over the last ten years is -72.92%. The current -237.65% ROE has changed 225.92% with respect to the historical average. Over the past ten years (40 quarters), TCON's ROE was at its highest in in the September 2022 quarter at 246.41%. The ROE was at its lowest in in the September 2023 quarter at -348.99%.

TRACON Pharmaceuticals, Inc. (TCON) ROE by Quarter and Year

Discovering the peaks and valleys of TRACON Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TRACON Pharmaceuticals, Inc. (TCON) Average ROE

How has TCON ROE performed in the past?

The current ROE of TRACON Pharmaceuticals, Inc. (TCON) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

TRACON Pharmaceuticals, Inc. (TCON) ROE vs. Peers

How is TCON’s ROE compared to its peers?

TRACON Pharmaceuticals, Inc.’s ROE is greater than Rezolute, Inc. (-69.83%), greater than XOMA Corporation (-33.68%), greater than Sio Gene Therapies Inc. (-78.26%), greater than Vincerx Pharma, Inc. (-307.54%), greater than Histogen Inc. (-80.69%), greater than Entera Bio Ltd. (-36.64%), greater than Tempest Therapeutics, Inc. (-187.44%), less than Better Therapeutics, Inc. (129.80%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Miromatrix Medical Inc. (-70.01%), greater than Inhibikase Therapeutics, Inc. (-350.62%), greater than PMV Pharmaceuticals, Inc. (-24.20%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Candel Therapeutics, Inc. (3.21%), greater than Acurx Pharmaceuticals, Inc. (-67679.28%), greater than Monopar Therapeutics Inc. (-21731.73%), greater than Enochian Biosciences, Inc. (-73.71%), greater than Kronos Bio, Inc. (-64.55%), greater than Cyclerion Therapeutics, Inc. (-55.31%), greater than Larimar Therapeutics, Inc. (-35.87%), less than Addex Therapeutics Ltd (105.53%), greater than Achilles Therapeutics plc (-54.57%),

Build a custom stock screener for TRACON Pharmaceuticals, Inc. (TCON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TRACON Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TRACON Pharmaceuticals, Inc. (TCON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TRACON Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.